Clinical Trial Update: Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for an oral hepatitis C treatment in indolent lymphoma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Liver Disease | Phase 4 | Status: TERMINATED | Results posted: 2019-01-08